FDA Logo links to FDA home page
Center for Biologics Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Biologics Evaluation and Research
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | CBER A-Z Index | CBER Search | Contact CBER | CBER Home Page

horizontal rule
CBER links to product areas Blood Vaccines Cellular/Gene Therapy Tissue Devices
CBER links Products Industry Healthcare Reading Room Meetings What's New
horizontal rule

Open Public Meeting - Human Bone Allograft

August 2, 2000 - Slide Presentation

horizontal rule

Overview of Relevant Comments to the Proposed Rules Dockets Concerning Regulation of Bone Products

Martha A. Wells CBER, FDA

horizontal rule

Review of Comments to Dockets of Proposed Regulations

  • 5/14/98 Establishment Registration and Listing for Manufacturers of Human Cellular and Tissue-Based Products
  • 9/30/99 Suitability Determination for Donors of Human Cellular and Tissue-Based Products

horizontal rule

General Comments: Homologous Use and Minimal Manipulation

  • Terms are vague - subject to broad interpretation
  • Do not reflect clinical use of the products
  • Questions on how the criteria will be applied
  • Should be eliminated
  • Agrees with the focus on promotion and labeling rather than the intent of the practitioner
  • Requests more guidance on how the definition will be applied

horizontal rule

Comments: Bone in General

  • Support/Against regulation of allograft
  • Against further/additional regulation
  • Against interference with patient care, doctor-patient relationship, practice of medicine
  • Support/Against regulating bone allograft as a medical device
  • Mechanical shaping of bone is minimal manipulation

horizontal rule

Concerns:Regulation of Bone

  • Curtailment of supply
  • Increased cost without increased safety
  • Satisfaction with industry standards
  • Manipulation of bone by shaping should not determine the level of regulation
  • Long history of safe use
  • FDA lacks authority to impose premarket approval oversight on allograft bone

horizontal rule

Comments: Bone Dowels

  • Support/Against regulatory evaluation of machined or formed allografts as devices
  • Support/Against regulation of allograft for procedures requiring stabilization
  • Premachined dowels are superior to those machined in the operating room
  • Mechanical shaping is not more than minimal manipulation
  • Against regulation based on the shape of bone
  • Shaping of bone by manufacturer should be regulated the same as shaping by the surgeon
  • Superior to similar metal devices
  • Should undergo the same degree of regulation as required for metallic implants

horizontal rule

Conclusion

  • Can't satisfy everyone- conflicting views
  • Majority of comments based on misinformation spread by interested parties - all bone as devices
  • More information is needed on bone allografts and their use
  • Clarification of the definitions is needed
  • Possible need for guidance

 

 
horizontal rule